|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 66.1 TWD | +0.30% |
|
+0.15% | +31.41% |
| 07/05 | TSH Biopharm Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 11/03 | TSH Biopharm Corporation Limited Announces Directorate Changes on April 1, 2024 | CI |
TSH Biopharm Corporation Limited reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 200.49 million compared to TWD 144.86 million a year ago. Net income was TWD 40.93 million compared to TWD 10.68 million a year ago.
Basic earnings per share from continuing operations was TWD 1.07 compared to TWD 0.28 a year ago. Diluted earnings per share from continuing operations was TWD 1.06 compared to TWD 0.28 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +31.41% | 78.82M | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +13.79% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
TSH BIOPHARM CORPORATION LIMITED 
